"Bei Asklepios steht der Mensch im Mittelpunkt. Unsere Mitarbeiterinnen und Mitarbeiter behandeln in unseren Klinken und Lehrkrankenhäusern bundesweit pro Jahr mehr als zwei Millionen Patientinnen und Patienten auf höchstem medizinischen Niveau nach höchsten Qualitätsstandards. Dabei verfolgen wir stets den Anspruch, jeder Patientin und jedem Patienten eine bestmögliche Behandlung in einem jederzeit sicheren Umfeld bei gleichzeitig persönlicher Zuwendung zukommen zulassen. Ob Krankenhaus der Maximalversorgung, spezialisierte Fach- oder Rehaklinik, bei uns werden Sie von hochqualifizierten Fachkräften nach modernsten medizinischen Standards versorgt."

During the past decade, Asklepios Klinik Altona conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 16 clinical trials were completed, i.e. on average, 32.7% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 12 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Asklepios Klinik Altona" #1 sponsor was "Janssen Research & Development, LLC" with 7 trials, followed by "Universitätsklinikum Hamburg-Eppendorf" with 7 trials sponsored, "University of Ulm" with 6 trials sponsored, "Biotronik SE & Co. KG" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 54 different institutions and companies that sponsored additional 53 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Asklepios Klinik Altona" #1 collaborator was "ClinAssess GmbH" with 2 trials as a collaborator, "ARMO BioSciences" with 1 trials as a collaborator, "Aesculap AG" with 1 trials as a collaborator, "Alfried Krupp Krankenhaus" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Asklepios Klinik Altona" are "Multiple Myeloma" (7 trials), "Acute Myeloid Leukemia" (4 trials), "Acute Myeloid Leukemia (AML)" (3 trials), "Colorectal Cancer" (3 trials) and "Ischemic Stroke" (3 trials). Many other conditions were trialed in "Asklepios Klinik Altona" in a lesser frequency.

Most popular intervention types in "Asklepios Klinik Altona" are "Drug" (57 trials), "Device" (19 trials), "Biological" (11 trials), "Procedure" (7 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (10 trials), "Placebo" (7 trials), "Carfilzomib" (6 trials), "Cytarabine" (5 trials) and "Lenalidomide" (5 trials). Other intervention names were less common.

The vast majority of trials in "Asklepios Klinik Altona" are 84 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Asklepios Klinik Altona". undefined are not yet recruiting, 24 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Asklepios Klinik Altona, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Asklepios Klinik Altona, 5 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 5 trials that are defined as “Not Applicable".